BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1450701)

  • 1. Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial.
    Utili R; Sagnelli E; Giusti G; Ruggiero G; Piccinino F; Galanti B; Adinolfi LE; Aprea L; Cesaro G; Digilio L
    Arch Virol Suppl; 1992; 4():277-80. PubMed ID: 1450701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe exacerbation of chronic hepatitis B following interferon therapy].
    Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
    Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of interferon alpha alone or after prednisone withdrawal in chronic hepatitis B. Interim report and review of the literature.
    Gonzalez-Mateos F; Garcia-Monzon C; Garcia-Buey L; Garcia-Sanchez A; Pajares JM; Moreno-Otero R
    Hepatogastroenterology; 1995; 42(6):893-9. PubMed ID: 8847042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.
    Lok AS; Wu PC; Lai CL; Lau JY; Leung EK; Wong LS; Ma OC; Lauder IJ; Ng CP; Chung HT
    Gastroenterology; 1992 Jun; 102(6):2091-7. PubMed ID: 1587429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial.
    Rakela J; Wood JR; Czaja AJ; O'Brien PC; Taswell HF; Bowyer BA; Lange SM; Anderson ML; Parent K
    Mayo Clin Proc; 1990 Oct; 65(10):1330-5. PubMed ID: 2214880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
    Utili R; Sagnelli E; Gaeta GB; Galanti B; Nardiello S; Felaco FM; Pasquale G; Marrone A; Aprea L; Pizzella T
    J Hepatol; 1994 Feb; 20(2):163-7. PubMed ID: 8006395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C; Rougier P; Bizollon T; Poupon R; Zarski JP; Quinton A; Miguet JP; Causse X; Chossegros P; Chevallier M
    J Hepatol; 1991; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-interferon treatment in Chinese patients with chronic hepatitis B.
    Lok AS; Lai CL; Wu PC; Lau JY; Leung EK; Wong LS; Fung YL
    J Hepatol; 1990; 11 Suppl 1():S121-5. PubMed ID: 2079568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver.
    Reichen J; Bianchi L; Frei PC; Malé PJ; Lavanchy D; Schmid M
    J Hepatol; 1994 Feb; 20(2):168-74. PubMed ID: 8006396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study.
    Fevery J; Elewaut A; Michielsen P; Nevens F; Van Eyken P; Adler M; Desmet V
    J Hepatol; 1990; 11 Suppl 1():S108-12. PubMed ID: 2079566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
    Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
    N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
    Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
    S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.